A major Swedish study of 247,420 individuals with attention-deficit/hyperactivity disorder (ADHD) has found that medication ...

The approach extends beyond classrooms. Schools are involving parents and counsellors to jointly craft personalised support ...

DELAWARE, DE, UNITED STATES, July 4, 2025 /EINPresswire.com/ -- The global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach USD 18.3 billion by 2025, as a result of ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

GPs in New South Wales who have undergone training will be able to resupply ADHD medication to patients who have already been ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Attention-deficit/hyperactivity disorder (ADHD) medications remain associated with a reduced risk for various real-world ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

Discover a study that explores how a personalised mHealth exercise program can effectively improve ADHD symptoms in children.